These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15059132)

  • 1. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.
    Ljungman P
    Br J Haematol; 2004 Apr; 125(2):107-16. PubMed ID: 15059132
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytomegalovirus and blood transfusion].
    Eggen BM
    Tidsskr Nor Laegeforen; 1993 Jan; 113(1):22-4. PubMed ID: 8380944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted cytomegalovirus infection.
    Bowden RA
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):155-66. PubMed ID: 7737939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-transmitted cytomegalovirus: lessons from a murine model.
    Roback JD; Su L; Zimring JC; Hillyer CD
    Transfus Med Rev; 2007 Jan; 21(1):26-36. PubMed ID: 17174218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in transfusion therapy.
    Beck SJ
    Clin Lab Sci; 1994; 7(4):225-31. PubMed ID: 10147432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leukocyte depletion of blood products. Indications and technical implementation].
    Böck M; Heim MU
    Fortschr Med; 1995 Mar; 113(8):102-4. PubMed ID: 7759031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
    Reesink HW; Engelfriet CP; Tegtmeier GE; O'Riordan J; Eglin R; Barbara JA; Flanagan P; Lin CK; Rawlinson W; Muylle L; Wendel S; Biagini S; Lazar AE; Krusius T; Alitupa E; Grillner L; Preiser W; Doerr HW; Brand A; Zupanska B; Brojer E; Degré M
    Vox Sang; 2002 Jul; 83(1):72-87. PubMed ID: 12100393
    [No Abstract]   [Full Text] [Related]  

  • 8. Indications for the use of cytomegalovirus-seronegative blood products.
    Preiksaitis JK
    Transfus Med Rev; 1991 Jan; 5(1):1-17. PubMed ID: 1666324
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical benefits of the leukoreduction of blood products.
    Blajchman MA
    J Trauma; 2006 Jun; 60(6 Suppl):S83-90. PubMed ID: 16763486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cytomegalovirus infection by using leukocyte-depleted components.
    Sayers M
    Curr Stud Hematol Blood Transfus; 1994; (60):41-52. PubMed ID: 8088169
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of leukocyte depletion in the prevention of transfusion-induced cytomegalovirus infection.
    Andreu G
    Semin Hematol; 1991 Jul; 28(3 Suppl 5):26-31. PubMed ID: 1656529
    [No Abstract]   [Full Text] [Related]  

  • 12. [The eclectic cellular tropism of cytomegalovirus].
    Landini MP; Jahn G
    Pathologica; 2000 Apr; 92(2):51-7. PubMed ID: 10838868
    [No Abstract]   [Full Text] [Related]  

  • 13. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening?
    Preiksaitis JK
    Transfus Med Rev; 2000 Apr; 14(2):112-36. PubMed ID: 10782497
    [No Abstract]   [Full Text] [Related]  

  • 14. New insights for preventing transfusion-transmitted cytomegalovirus and other white blood cell-associated viral infections.
    Roback JD; Josephson CD
    Transfusion; 2013 Oct; 53(10):2112-6. PubMed ID: 24099337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transmission of viral infections during transfusion of blood and its components].
    Agranenko VA; Krizhevskaia IuV
    Gematol Transfuziol; 1991 Jun; 36(6):25-7. PubMed ID: 1663054
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a new Light Diagnostics and the CMV Brite to an in-house developed human cytomegalovirus antigenemia assay.
    Percivalle E; Genini E; Chiesa A; Gerna G
    J Clin Virol; 2008 Sep; 43(1):13-7. PubMed ID: 18468948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion support in liver transplantation.
    Triulzi DJ
    Curr Hematol Rep; 2004 Nov; 3(6):444-9. PubMed ID: 15496279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus and other herpes viruses.
    Lang DJ; Drew WL
    Transfus Med Rev; 1988 Dec; 2(4):294-5. PubMed ID: 2856532
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
    Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
    Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.